Resmed Inc
XBER:RME
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
Resmed Inc
XBER:RME
|
US |
|
Dream Impact Trust
OTC:DDHRF
|
CA |
|
T
|
Tesla Inc
XBER:TL0
|
US |
|
Guotai Junan Securities Co Ltd
OTC:GUOSF
|
CN |
|
Stellantis NV
F:8TI
|
NL |
Wall St Price Targets
RME Price Targets Summary
Resmed Inc
According to Wall Street analysts, the average 1-year price target for RME is 229.46 EUR with a low forecast of 164.54 EUR and a high forecast of 308.84 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RME's stock price target?
Price Target
229.46
EUR
According to Wall Street analysts, the average 1-year price target for RME is 229.46 EUR with a low forecast of 164.54 EUR and a high forecast of 308.84 EUR.
What is the Revenue forecast for Resmed Inc?
Projected CAGR
7%
Over the last 14 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 3 years is 7%.
What is the Gross Profit forecast for Resmed Inc?
Projected CAGR
9%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 11%. The projected CAGR for the next 3 years is 9%.
What is the Operating Income forecast for Resmed Inc?
Projected CAGR
10%
Over the last 14 years, the compound annual growth rate for Operating Income has been 14%. The projected CAGR for the next 3 years is 10%.
What is the Pre-Tax Income forecast for Resmed Inc?
Projected CAGR
12%
Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been 13%. The projected CAGR for the next 2 years is 12%.
What is the Net Income forecast for Resmed Inc?
Projected CAGR
11%
Over the last 14 years, the compound annual growth rate for Net Income has been 14%. The projected CAGR for the next 3 years is 11%.
